Intestinal Schistosomiasis in Africa

@article{Fedail2019IntestinalSI,
  title={Intestinal Schistosomiasis in Africa},
  author={Suliman Salih Fedail},
  journal={Digestive Diseases in Sub-Saharan Africa},
  year={2019}
}
  • S. Fedail
  • Published 2019
  • Medicine
  • Digestive Diseases in Sub-Saharan Africa
1 Citations
Inactivation of Schistosoma Using Low-Temperature Plasma
TLDR
The inactivation of Schistosoma mansoni cercariae and miracidia was achieved by exposure to plasma produced by the positive, negative, and axial negative corona discharges, and the water pre-activated by the discharges showed similar efficiency.

References

SHOWING 1-7 OF 7 REFERENCES
Human schistosomiasis
Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges
TLDR
The antischistosomal drugs currently used in the treatment of intestinal schistosomiasis caused by Schistosoma mansoni, as well as issues regarding the evidence for drug resistance and combination studies are reviewed in a simple manner.
Prevalence and common genotypes of HCV infection in Sudanese patients with hepatosplenic schistosomiasis
TLDR
It is concluded that HCV was of low seroprevalence in the study population and that parenteral antischistosomal therapy was not a significant risk factor in transmission of infection in the Sudan.
Human schistosomiasis
Current concepts - Schistosomiasis
TLDR
In 1851, Theodor Bilharz described a parasitic infection (bilharzia) that would later be termed schistosomiasis, which is caused by parasitic trematode worms that reside in the abdominal veins of their vertebrate definitive hosts.
Esophageal varices in Sudan.
  • S. Fedail
  • Medicine
    Gastrointestinal endoscopy
  • 2002